Table 3.
Patient demographics and Clostridium difficile-infection related outcomes
| WellStar | Florida | |
|---|---|---|
| Patient characteristics | N = 36 | N = 28 |
| Age | 68.6 ± 16.7 | 82 ± 10.2 |
| Gender: Male | 18 (50%) | 14 (50%) |
| Race | ||
| Caucasian | 22 (61%) | 23 (82%) |
| African American | 5 (14%) | 1 (3.0%) |
| Other | 9 (25%) | 4 (14%) |
| Admission source | ||
| Community | 27 (75%) | 15 (57%) |
| Other healthcare facility | 9 (25%) | 12 (43%) |
| Previous hospitalization | 5 (14%) | 17 (61%) |
| Episode | ||
| Initial episode | 32 (89%) | 20 (71%) |
| First recurrence | 4 (11%) | 6 (21%) |
| > 2 recurrences | NA | 2 (7%) |
| CDAD present within 24 h | 15 (42%) | 17 (61%) |
| Top comorbidities | ||
| Moderate to severe renal disease | 20 (56%) | 6 (18%) |
| Diabetes | 19 (53%) | 9 (27%) |
| Cardiovascular disease | 17 (47%) | 15 (54%) |
| Fidaxomicin treatment (days) | 8.4 ± 3.6 | 7.9 ± 5.2 |
| Outcomes | ||
| Pathway adherence | 36/120 (30%) | 28/142 (20%) |
| Recurrence 30 day | 0 | 2 (7%) |
| Recurrence 60 day | 0 | 3 (9.7%) |
| Readmission | 5 (14%) | 6 (21%) |
| Readmission related to CDAD | 0 | 3 (50%) |
| Clinical cure | 30 (83%) | 26 (93%) |